S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

KALV KalVista Pharmaceuticals Inc

9.96

0.16 (1.63%)

Nov 15 2024 - Closed

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

KalVista Pharmaceuticals (NASDAQ:KALV)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more KalVista Pharmaceuticals Charts.

KalVista Pharmaceuticals (NASDAQ:KALV)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more KalVista Pharmaceuticals Charts.

KalVista Pharmaceuticals Inc News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 days ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (2 days ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 13 November 2024 (3 days ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 12 November 2024 (4 days ago) • Edgar (US Regulatory)

KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
Tuesday 12 November 2024 (4 days ago) • Business Wire

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 7 November 2024 (1 week ago) • Edgar (US Regulatory)

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 5 November 2024 (2 weeks ago) • Business Wire

Form 8-K - Current report
Monday 4 November 2024 (2 weeks ago) • Edgar (US Regulatory)

KalVista Pharmaceuticals Announces Pricing of a $55 Million Underwritten Offering of Common Stock and Concurrent Private Placement of $5 Million
Monday 4 November 2024 (2 weeks ago) • Business Wire

Form 8-K - Current report
Monday 4 November 2024 (2 weeks ago) • Edgar (US Regulatory)

KalVista Pharmaceuticals Enters into Non-Dilutive Synthetic Royalty Financing with DRI Healthcare Trust
Monday 4 November 2024 (2 weeks ago) • Business Wire

KalVista Pharmaceuticals Presents New Sebetralstat Data at the 2024 American College of Allergy Asthma and Immunology
Monday 28 October 2024 (3 weeks ago) • Business Wire

More KalVista Pharmaceuticals Inc News Articles

Super Micro Computer

CyberFuels (PK)

AMC Entertainment

Bioelectronics (PK)

NioCorp Developments

Global Developments (PK)

Decentral Life (PK)

Elite Pharmaceuticals (QB)

Digital Brand Media and ... (PK)

North Bay Resources (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions